Cytokinetics (CYTK) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

51.960
-0.060-0.12%

Trading Nov 27 09:39 ET

6.13BMarket Cap-9657P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Sale: Director at $CYTK (CYTK) Sells 742 Shares
Quiver Quantitative17:46 ET
Calculating The Intrinsic Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)
Simply Wall StNov 26 08:45 ET
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Zacks Nov 22 13:00 ET
Cytokinetics Price Target Raised to $103 From $99 at Mizuho
Yahoo FinanceNov 22 06:51 ET
Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?
Yahoo FinanceNov 21 17:39 ET
Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $103
BenzingaNov 21 08:10 ET · Ratings

Comments

Sean Parker

Nov 19 02:56

$Cytokinetics (CYTK.US)$
Cytokinetics (CYTK) and Bayer have established an exclusive licensing agreement for aficamten in Japan, focusing on treating hypertrophic cardiomyopathy (HCM). The deal includes an upfront payment of €50 million to Cytokinetics, with potential additional earnings of €90 million in milestones through commercial launch (including €20 million near-term) and up to €490 million in commercial milestone payments. The collaboration involves tiered royalties on Japanese sales and ...

Mr Long Term

Aug 13 17:42

Columns Top Calls on Wall Street: Starbucks, Dell, Warner Bros. and More.

Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...